Continuum Advisory’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Continuum Advisory's RPRX Position: Q2 2026 in Review
Continuum Advisory opened a new position in Royalty Pharma (RPRX) in Q2 2026: 427 shares worth $23.9K. The stake represents ﹤0.01% of the portfolio and ranks #995 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in RPRX as recently as Q1 2025.
Continuum Advisory first reported a position in RPRX in Q1 2025 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Continuum Advisory held 427 shares of Royalty Pharma worth $23.9K as of Q2 2026.
- Royalty Pharma was a new Continuum Advisory position in Q2 2026.
- Royalty Pharma made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #995 holding.
- Continuum Advisory first reported a position in Royalty Pharma in Q1 2025 and has held it in 2 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.